Annual Conference

3 September 2024 – Novartis Campus Basel, Switzerland

Combined products of tomorrow – developing solutions for and with patients

Advanced Program

Welcome and introduction

09.00 – 09.15

Shayesteh Fürst-Ladani (MPP President)

Mike Wallenstein (Chair of MPP2024 Program Committee, Novartis)

Session 1 – Connected combined products and digital health

09.15 – 10.30

Short presentations followed by a Q&A

In this session, representatives from notified bodies, academia, patients and the industry will exchange perspectives on topics including artificial intelligence, data security aspects and digital health in regard to connected combined products.

Chairs: Theresa Jeary (BSI) & Nathalie Schober-Ladani (SFL, a Veristat company)

Marcel Schilling (German Cancer Research Center)
Abhineet Johri (Siemens Healthineers)
Thomas Doerge (BSI)
Lada Leyens (Takeda)


10.30 – 11.00

Session 2 – Combined use of IVDs/CDx with medicinal products

11.00 – 12.15

Short presentations followed by a Q&A

This session will revolve around the combined use of in vitro diagnostics (IVDs) and Companion Diagnostics (CDx) with medicinal products with a focus on the In Vitro Diagnostics Regulation (IVDR), its implementation and interaction with other relevant legislations.

Chairs: Marie-Claire Beurier (Roche) & Fanny Barbotin (BD)

Marianne Lunzer (AGES, HMA CTCG)
James Hewitt (TÜV SÜD)
Fatima Bennai-Sanfourche (Bayer)


12.15 – 13.45


13.45 – 15.15

Opening statements followed by a moderated debate and Q&A

The panel will feature representatives from regulatory authorities and the industry who will share perspectives on national and regional regulatory strategies, current challenges, and recent developments in relation to the regulation of combined products, including ongoing harmonization efforts at a global level.

Moderator: Mike Wallenstein (Chair of MPP2024 Program Committee, Novartis)

Karoline Mathys (Swissmedic)
James Bertram (US FDA)
Françoise Schlemmer (Team-NB)
Theresa Jeary (BSI)
Ruth Foster (MSD)


15.15 – 15.25

Kaspar Sutter (Canton of Basel City)

Break & Apero

15.25 – 16.15

Session 3 – Patients’ inclusion and perspectives on the lifecycle of combined products

16.15 – 17.30

Short presentations followed by a Q&A The session will discuss the inclusion of patients and caregivers in the lifecycle of combined products.

Chairs: Jasmin Barman-Aksözen (International Porphyria Patient Network (IPPN)) & Mike Wallenstein (Novartis)

Steven Bourke (PersonalPulse)
Conny Berlin (Novartis)
Mimi Choon-Quinones (Partners for Patients)

Wrap-up and closing

17.30 – 17.40

Shayesteh Fürst-Ladani (MPP President)

Mike Wallenstein (Chair of the MPP2024 Program Committee, Novartis)

Questions regarding the event organization

Questions regarding the conference program

Our Sponsors

Our Media Partners